Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) 2015, Natural Capsules has informed that 148th meeting of the Board of Directors of the Company is scheduled on Friday, 28th day of October, 2022 to consider and take on record, the following items: To Consider and approve the Unaudited Consolidated & Standalone Financial Results of the Company for the Quarter & half Year ended September 30th 2022 and To discuss on making further call on balance right issue money. Pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company’s Code of Conduct for Prevention of Insider Trading and Code of Corporate Disclosure Practices, the ‘Trading Window’ for dealing in the equity shares of the Company has remained closed for all Designated Person and their immediate relatives with effect from 01st October 2022 till the conclusion of 48 hours after the declaration of financial results of the Company for the Quarter and half year ended 30th September, 2022.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: